Please login to the form below

Not currently logged in
Email:
Password:

The Saatchi & Saatchi Health Award for Launch Excellence

Sponsored by

Finalist

Dovobet ® Gel Designed with Patients in Mind

LEO Pharma in association with Langland


Summary of work

The LEO Pharma UK launch of Dovobet ® Gel (calcipotriol/betamethasone dipropionate) in January 2011 was the largest in the history of dermatology. 

Psoriasis is a chronic, incurable skin condition, the physical and mental impact of which can be more damaging to quality of life than cancer. Yet GP apathy is common. 

Despite recognition of the issues their patients were facing, lack of resources to understand the cause prevented GPs intervening. They didn’t realise that patients struggle with current psoriasis treatments and that poor adherence and outcomes are a huge issue. These difficult experiences and lack of support compounded patients’ feelings of isolation, often withdrawing from society.

This insight formed the basis of our approach. We HAD to improve outcomes, combining the launch of a desperately needed improved treatment option with solutions to aid adherence, mobilise and re-energise those who’d lost hope and reduce the psychological impact of psoriasis. GPs needed to become more empathetic and understand why acceptable treatments and support were essential to improve outcomes.

Through extensive, consultative pre-launch planning, a ground-breaking campaign was developed. The insight driven approach resulted in an incredible response, over-achieving all objectives post-launch and global adoption of the strategic framework as best practice for LEO.

 

 

Executive summary as submitted


PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics